Draft Genome Sequence of a Drug-Susceptible New Zealand Isolate of Mycobacterium tuberculosis Lineage 3-Reference-Cited by-同舟云学术

Draft Genome Sequence of a Drug-Susceptible New Zealand Isolate of Mycobacterium tuberculosis Lineage 3

Published:2015-06-25 Issue:3 Volume:3 Page:
ISSN:2169-8287
Container-title:Genome Announcements
language:en
Short-container-title:Genome Announc

Author:

Mac Aogáin Micheál¹,Bower James E.²,Basu Indira²,Freeman Joshua T.²,O’Toole Ronan F.³

Affiliation:

1. Department of Clinical Microbiology, School of Medicine, Trinity College Dublin, St. James's Hospital, Dublin, Ireland

2. LabPlus, Auckland City Hospital, Auckland, New Zealand

3. Breathe Well NHMRC Centre of Research Excellence, School of Medicine, University of Tasmania, Hobart, Tasmania, Australia

Abstract

ABSTRACT We report here the draft whole-genome sequence of a drug-susceptible lineage 3 (East-African Indian) isolate of Mycobacterium tuberculosis from New Zealand (NZ3DS1) and compare it to a multidrug-resistant lineage 3 isolate (NZ3MDR1) with an identical 24-locus mycobacterial interspersed repetitive-unit–variable-number tandem-repeat profile.

Publisher

American Society for Microbiology

Subject

Genetics,Molecular Biology

Link

https://journals.asm.org/doi/pdf/10.1128/genomeA.00499-15

Reference11 articles.

1. World Health Organization. 2014. Global tuberculosis report. WHO, Geneva, Switzerland.

2. Phylogenetic lineages of tuberculosis isolates in New Zealand and their association with patient demographics

3. Variable host-pathogen compatibility in Mycobacterium tuberculosis

4. Major Mycobacterium tuberculosis Lineages Associate with Patient Country of Origin

5. Draft Genome Sequence of a Multidrug-Resistant New Zealand Isolate of Mycobacterium tuberculosis Lineage 3